Application of VIP intervention mode in patients with advanced tumors in the western region of China

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200056852

Enrollment

Unknown

Registered

2022-02-20

Start date

2020-04-01

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced tumors

Interventions

Experimental group:Routine disease and symptom nursing and health education + ‘’VIP for future care’’ model intervention

Control group:Routine disease and symptom nursing and health education

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Patients with advanced cancer (cancer diagnosed as stage ? or ?); 3. The Montreal Cognitive Assessment (MoCA) score >=26; 4. Know the condition; 5. Not signed advance directives (ADs).

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders or diseases; 2. Cannot tolerate long time communication; 3. The patient refused to participate.

Design outcomes

Primary

Measure	Time frame
the quality of life;	—

Secondary

Measure	Time frame
intention for end-of-life care;patient decision certainty;	—

Countries

China

Contacts

Public ContactXie Nan

1320592456@qq.com.+86 825 2292207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026